For the first time, the new ACR/EULAR gout classification criteria incorporate ultrasound (US) evidence of double contour sign (DC), an articular cartilage abnormality related to the deposition of crystals on the surface of the hyaline cartilage, as a sign specific to gout. US recently has been used as an objective diagnostic tool for detecting urate deposition (tophus (T), DC) or joint damage (erosion) in gout. Objective: Our aim was to investigate the relationship between clinical gout activity and load of US changes, also to examine the concordance between patient reported joint attack (PRGA) and ultrasonographic intraarticular changes. Methods: Sixty monosodium-urate-crystal-confirmed gout patients and 36 healthy controls were prospectively included in one centre. The relationship between clinical symptoms and ultrasonographic gout-related changes investigating 36 joints and 4 tendons (m. triceps and patellar) was evaluated using Spearman's correlation and agreement analysis (kappa coefficient). Results: moderate, positive correlation was observed between the number of subcutaneous tophi and total US tophus area (rs=0,628), total number of DC (rs=0,612), and erosions (rs=0,526), all p<0, 0001, found per patient on US. Gout attacks and disease duration significantly positively correlated with the load of all investigated US changes (p<0, 01).
Introduction
The golden standard for gout diagnosis is the demonstration of negatively birefringent, needle-shaped monosodium urate crystals in the synovial fluid [1] . However, obtaining synovial fluid requires training and operator comfort, so most primary care or emergency room doctors choose clinical judgement instead of joint aspiration [1, 2] . Clinical signs, such as the number of gout attacks per year, the total number of gout attacks per life, and clinically detectable tophi are considered as markers of dise-ase severity, according to which the decision for hypouricemic treatment for many years has been made [3, 4] . The use of non-invasive radiologic diagnostic techniques, such as high-resolution ultrasound or dual-energy CT (DECT) for gout diagnosis, incorporated into the recent 2015 ACR/ EULAR gout classification criteria [5] let us visualise the MSU crystal deposits, as well as measure the total body urate burden in the joints and periarticular structures [6, 7] . High-resolution ultrasound (US) was shown to be more sensitive than conventional radiography in revealing joint damage -joint erosions -in gout [8] . US might be a tool for measuring the response to therapy in gout [9, 10] . Relying on that, gout experts at the OMERACT 9 gout workshop stated that the number of gout attacks, the physical measurement of subcutaneous tophi (T), in combination with US assessment of intraarticular T may contribute to a definition of remission in patients with gout [11] . But there is a lack of studies investigating the relationship between the clinical symptoms and spread of US findings in gout. The studies with asymptomatic hyperuricemia [12, 13] or gout studies investigating both: the symptomatic and the contralateral joint [14] showed that T, double contour (DC), and even erosions (E) can be found in the joint, in which symptoms have never been reported, raising the question of concordance between the clinics and US changes. Which joints should be investigated for gout classification, just the symptomatic joints or more, independently of symptoms, this is still a matter of discussion.
Our goal was to determine if there is a relationship between the clinical severity of gout and US urate load or joint damage visible on ultrasound, also to determine how big the concordance is between patient reported gout attack and intraarticular ultrasonographic findings.
Methods

Selection of patients.
The analysis was done within a case-control study conducted in 2014-2016 in one centre designed for investigation of sensitivity and specificity of US in gout, which prospectively included adult gout patients (60) attending a tertiary rheumatology unit during intercritical gout stage independently of disease duration and treatment and healthy normouricemic controls (36) as a comparator group. Gout diagnosis was confirmed by MSU crystal detection in synovial fluid from symptomatic ever joint or bursa under polarised light microscopy independently by two study investigators -rheumatologists (EN and IA) in all cases. The sensitivity and specificity of intraarticular US T, DC, and erosion according controls was estimated to be 85% and 83% (p<0, 0001), 87% and 86% (p<0, 0001), 63% and 70% (p=0,003), respectively. To eliminate the potential impact of hypouricemic treatment to the sensitivity of US [9, 10] , some statistical analysis in this study was done excluding patients treated with hypouricemic drugs. Only patients capable to recall the sites of gout attacks were selected for concordance analysis between the clinical joint involvement and US signs of urate deposition.
The study was approved by the Lithuanian University of Health Sciences Kaunas Region Biomedical Research Ethics Committee. Written informed consent was obtained from all subjects before study entry.
Laboratory and clinical investigation. All patients underwent blood sampling for CRP, creatinine, and serum uric acid (SUA), also clinical investigation, done by a qualified rheumatologist (EN). Height, weight, and subcutaneous tophi were recorded. A detailed disease history was taken of gout symptom duration, number of gout attacks per life/ per last year and joints with gout attacks, reported by patient were recorded in a special form or on homunculus, when suitable. The gout attack was described as a sudden onset of painful joint swelling, with maximum inflammation developing within one day and clearing within one to two weeks [3] . The number of gout attacks per life was counted as follows: exact number of gout attacks reported by patient during the first two years of disease plus medium number of attacks per year multiplied by years with symptoms in patients with disease duration more than two years.
Ultrasonographic assesment. Standardised US examination of 36 joints (both wrists, metacarpophalangeal (MCP), hand proximal interphalangeal (PIP), knees, ankles and metatarsophalangeals (MTPs)) and 2 tendons (m. triceps and patellar) was performed in a darkened room for all participants at the same day as clinical investigation by other rheumatologist (MP), with high experience (more than 10 years) in musculosceletal US, blinded to clinical data. The LOGIQ e US system with a 12 MHz linear transducer on B mode scale was used for US examination. All joints were scanned in the longitudinal plane dorsal side. Knees were explored on longitudinal and transversal planes in suprapatellar and parapatellar joint recesses on full extension of the leg for joint cavity evaluation, longitudinally in 20 degrees flexion for patellar tendon evaluation and transversally in maximal flexion to analyse femoral cartilage. The ankles were investigated on longitudinal plane dorsal and lateral sides. The views were chosen as per guidelines for musculoskeletal US [15] [16] [17] . Joints were investigated for the presence of DC, T and erosion. The US T was defined as circumscribed heterogeneous hyperechoic / isoechoic (relative to subdermal fat) sometimes with hypoechoic inclusions mass with or without small anechoic rim; the DC sign was defined as hyperechoic band over the super-substantial and > 0,80 almost perfect reliability [20] . The correlation between variables was determined using Spearman's correlation coefficient (rs). P values less than 0, 05 were considered significant.
Results
In all, 60 patients with gout were used for correlation analysis between clinical symptoms and US features. Fifty-five from them were able to report the symptomatic joints and were used for concordance analysis between patient reported gout attack and US. Twenty-eight patients were not using hypouricemic treatment. Table 1 . shows the demographic and clinical characteristics of the participants ( Table 1) .
The total number of intraarticular T, periarticular T, total T, total DC, and total E found per patient on ultrasound ranged from 0-26, 0-4, 0-30, ficial margin of the articular hyaline cartilage, visible independent of the angle of insonation [6, 9, 10, 15, 18] ; Erosion was defined as an intra-and /or extra-articular discontinuity of the bone surface (visible in two perpendicular planes) [15] The size of T was measured as the area of nodulus, considered to be US tophus, calculated by continuous tracing around the outline of the nodulus and calculating the area enclosed within the outline, measured using the integrated software in the US machine [19] (figure 1).
Statistical analysis. Statistical analysis was performed using SPSS statistical software version 20.0 SPSS, Chicago, Illinois, USA. The study sample was described as mean ±SD or median for continuous variables and frequency (%) for categorical variables. Concordance between intraarticular B-US findings and patient reported joints with previous gout symptoms, was done using unweighted Cohen's κ -statistics in terms of dichotomous assessment (i.e. presence or absence) and interpreted as follows: 0-0,20 represent slight; 0,21-0,40 fair; 0,41-0,60 moderate; 0,61-0,80 Gout symptoms duration, y median There was positive correlation between the total number of joints with gout attacks reported by patients with intraarticular T, periarticular T, total T, total DC, and total intraarticular E found per patient on US with rs=0,459, rs=0,515, rs=0,555, rs=0,509 and rs=0,325, respectively with all p<0,001.
Gout group N60
Gout group N55
Correlation between US findings and subcutaneous tophus, detected by rheumatologist. There was a positive correlation between the number of subcutaneous tophus found on clinical examination and the total number of tophus (rs=0,600), total tophus area (rs=0,628) (figure 2), DC (rs=0,612) and erosion (rs=0,526) (figure 3) detected on US (all p<0, 0001). The clinically visible tophi correlated with the disease duration (rs=0,718; p<0, 0001), the number of gout attacks per year (rs=0,514; p<0, 0001) and gout attacks per life (rs=0,752; p<0, 0001) (Figure 1,2) .
Correlation between US findings and uric acid concentration and CRP. There was no correlation between CRP and US changes: number of tophus (rs=0,141, p=0,286), DC (rs=0,220, p=0,093) or erosion (rs=0,100, p=0,450) found per patient. CRP positively correlated with the total number of joints with gout attacks reported by patient (rs=0,394; p<0, 01). There was no correlation between the uric acid concentration and US changes: total number of T (rs=0,193, p=0,139), DC (rs=0,179, p=0,170) or E (rs=0,063, p=0,634) found per patient in the whole (60) gout group; also no correlation in untreated (28) patient group. The concordance between intraarticular ultrasonographic gout changes and patient-reported gout attack. The strength of agreement between patient-reported gout attack and US signs of intraarticular urate deposition (US T, DC), also damage (erosion) was fair in heterogeneous according treatment group of 55 gout patients with US being up to 1.3 times more sensitive according signs of urate deposition but revealing 2.2 times fewer intraarticular erosions than clinical signs ( Table 3 . Concordance (κ value) between ultrasound (US) T, DC sign, erosion and clinical findings in the joints of hipouricemic treatment-naïve gout participants (28).
Data given as % of joints positive for : patient-reported symptoms of gout flare; and US tophus (T), double contour (DC), US tophus and double contour (UST/DC) or erosion (E) found on US examination. Concordance with US lesions given as κ values. PIP, proximal interphalangeal joint; MCP, metacarpophalangeal joint; MTP metatarsophalangeal joint; nd-evaluation not done.
the opposite -patients reported 1.3 times more symptoms compared to intraarticular US signs of urate deposition. The frequency of gout attacks in the joints with US signs of urate deposition is presented in the table 4.
Discussion
In this study we investigated the relationship between the subjective and objective signs of clinical disease activity and the burden of US changes in gout, investigating 36 joints and 4 tendons. It was the first attempt systemically to check the link between patient reported gout attacks and intraarticular ultrasonographic changes using multiple-joint investigation in gout.
We found a significant, mostly moderate [21] positive correlation between the patient reported number of gout attacks per year/per life, the number of subcutaneous tophi found by a rheumatologist per patient, and load of ultrasonographic signs of urate deposition. Clinical disease activity (objective and subjective symptoms) positively correlated with the joint damage -number of erosions found per patient on US. Gout-related US signs significantly moderately positively correlated with each other. These findings confirm the hypothesis that gout symptom severity and joint damage increases with the load of urate deposition in joints or periarticular tissues that is visible on ultrasound. Our study suggests that clinically visible subcutaneous tophi could be a prognostic marker of the magnitude of joint damage in gout. This is in agreement with Rajan's et al., study [22] which found the relationship between clinics and changes on dual-energy computed tomography (DECT) where urate volume correlated with the subcutaneous tophus count (rs=0,62, p< 0,0001), swollen joint count (rs= 0,32, p= 0,007), and flare frequency (rs= 0,26, p=0,03). The correlation between erosion and tophus area (rs=0,510) or tophus number (rs=0,646) was bigger than that with patient reported number of symptomatic joints (rs= 0,325), suggesting the tophus as being a bigger predictor for damage than clinical symptoms, which is also in agreement with other US studies showing the relationship between the tophus and erosion in the joint [23] . We did not find the correlation between CRP and total tophus area measured on US which was different from the previously mentioned Rajan et al., study [22] which reported a correlation between urate volume and C reactive protein (rs = 0, 36, p=0,002), but in agreement with Rajan et al., study according no relationship between uric acid and US changes, which could be explained by the fact that only 15% of our patients had uric acid concentration less than 360 mkmol/l -the expected therapeutic goal in gout treatment [4] . Investigating 1980 joints in 55 gout patients irrespecti-ve of treatment and disease duration, we found that concor-dance between patient reported gout attack in the joint and intraarticular US findings was fair with κ=0,333, 0,275, and 0,217 for tophus, DC, and erosion, respectively. There was a large number of clinically false negative joints with T and/or DC found on US (mostly radiocarpal, metatar-sophalangeal joints, indicating higher sensitivity of US in these cases, but also negative intraarticular US in symptomatic joints (mostly knees and ankles). The explanation for this could be periarticular involvement in some "arthritis" cases: figure 4 represents a case of intermittent gout attack in the ankle joint, as reported per patient, with no US changes in the anterior recess of the tibiotalar joint, but with periarticular US involvement.
Tophi in the patellar tendon (figure 1) visible on US could potentially cause swelling in the knee area and be dismissed by the patient as an "attack of arthritis". Frequent periarticular involvement is described in previous ultrasounds [6] , also DECT studies: DECT helped to diagnose gout in 11 out of 30 patients with undifferentiated arthritis/ tendinitis/enthesitis who had a negative synovial fluid-polarising microscopy from their initial diagnostic evaluation; periarticular involvement was shown on DECT in these cases [24] . Another reason of disagreement between clinical symptoms and US in the knee area found in our study might be low sensitivity of US regarding T in suprapatellar and parapatellar joint recesses. Perez-Ruiz et al. reported tophi lying deep in the inner collateral ligament in the knee joint, the area not evaluated in our study [9] . Better agreement, considered as moderate between PRGA and any sign of urate deposition (US T or DC) was found, investigating 1008 joints in untreated (28) or 720 joints in early (20) gout patients, with κ =0,498 andκ =0,400, respectively, indicating a potential impact of hypouricemic treatment to the sensitivity of US or some possible bias towards patients not recalling an attack properly in late gout. So we should not rely on just "symptomatic" joint investigation for US gout classification during intercritical gout stage, especially in advanced disease. Our study has some weaknesses such as the crosssectional design for the evaluation of the relationship between clinical symptoms and US, also the absence of other high-sensitivity imaging such as MRI or DECT [23, 26] . Nevertheless we checked the specificity of US using control group. There is still a need for longitudinal studies to confirm the relationship between clinics and US, also to confirm US tophi and DC as an outcome measure for gout.
Conclusions
Ultrasonographic changes positively correlate with subjective and objective signs of disease activity and disease duration in gout with fair to moderate concordance between patient-reported gout attack and intraarticular US findings. Not only symptomatic joint should be used for US gout classification in clinical practice.
